Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Environmental Research and Public Health|December 11, 2022
Clustering and Stochastic Simulation Optimization for Outpatient Chemotherapy Appointment Planning and SchedulingMajed Hadid, Adel Elomri, Regina Padmanabhan, et al.
Human Vaccines & Immunotherapeutics|April 17, 2026
Childhood immunization barriers and interventions in low- and middle-income countries: A scoping review of access, delivery systems, and health literacyYasmin Fatinah, Marsa Qolbina, Mohammed Alfaqeeh, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data EvaluationNour Hisham Al-Ziftawi, Mohammed Fasihul Alam, Shereen Elazzazy, et al.
Antibiotics (Basel, Switzerland)|December 30, 2025
The Cost of Resource Use Relative to the Development of the Antimicrobial Stewardship Program in a Tertiary Cancer Setting in QatarDina Abushanab, Diala Alhaj Moustafa, Anas Hamad, et al.
Journal of the American Pharmacists Association : Japha|June 6, 2024
Establishment of a clinical pharmacist-led multiple myeloma clinic with collaborative prescribing model at the national center for cancer care and research in QatarRola Ghasoub, Shereen Elazzazy, Maria Benkhadra, et al.
Frontiers in Oncology|October 31, 2024
HER2-low non-metastatic breast cancer in Qatar-a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysisAhmed Kardousha, Wafaa Shehada, Ahmed Basha, et al.
Frontiers in Oncology|January 1, 2024
The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a nationwide real world comparative retrospective cohort studyNour Hisham Al-Ziftawi, Shereen Elazzazy, Mohammed Fasihul Alam, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 26, 2025
Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular CarcinomaNabil E Omar, Hazem Elewa, Kareem A El-Fass, et al.
Annals of Saudi Medicine|February 4, 2019
Survival and metastasis in muscle-invasive bladder cancer patients who present with indeterminate pulmonary nodules before treatmentAli Al-Daghmin, Sohaib Alhamss, Hani Al-Najjar, et al.
Oncology|January 12, 2026
Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia: A Systematic ReviewAmna Gameil, Rola Ghasoub, Neda Jafari, et al.
Pageof 6